Content continues after advertisement

Research Note: The Many Possibilities of Antitumor Vaccines

Clinician's Brief (Capsule)


|March 2014

Sign in to Print/View PDF

This study explored the possibilities of redirecting the immune system to generate an antitumor response. Tumor-associated antigens (TAAs) are not found on normal cells. TAAs associated with the tumor stroma are important, as immunity against TAAs could restrict tumor ability to metastasize and grow. Immunoediting refers to a process in which immune selection pressure favors growth of tumor cells. This occurs via alteration in antigen processing and presentation, production of immunosuppressive cytokines by tumor cells, and activation of immune-suppressive T-cell populations.

One of the most promising areas for clinical application is in the development of vaccines based on purified recombinant protein or nucleic acid TAAs. Vaccines reflect various strategies: Inactivated autologous or allogenic cancer cells, patient dendritic cells that have undergone in vitro stimulation, TAAs or proteins necessary for tumor progression, or recombinant vectors for antigen delivery. For instance, a vaccine against melanoma is based on immunization with DNA components of tyrosinase, a glycoprotein that synthesizes melanin. One way of increasing efficacy of antitumor vaccines is to add immunostimulatory molecules, such as interleukin-2 or a novel extracellular matrix vaccine adjuvant. Increased benefit often occurs when vaccines produced from harvested tumor material provide the broadest range of antigenic targets. Cancer immunotherapy is an exciting area of research that may provide treatment options with decreased potential for adverse effects, likely yielding productive data for both human and veterinary patients.


Cancer vaccines: Harnessing the potential of anti-tumor immunity. Suckow MA. VET J 198:28-33, 2013.

This capsule is part of the One Health Initiative.

For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.


Clinician's Brief:
The Podcast
Listen as host Alyssa Watson, DVM, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2022 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Terms & Conditions | DMCA Copyright | Privacy Policy | Acceptable Use Policy